[{"AccountsPayableCurrent_0_Q2_USD":1372000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1253000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":99000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_2_Q2_USD":0.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":0.0,"PrepaidInsurance_0_Q2_USD":2722000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":4204000.0,"PreferredStockDividendsIncomeStatementImpact_2_Q2_USD":0.0,"PreferredStockDividendsIncomeStatementImpact_1_Q2_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":720000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":0.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-145000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":9983000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-80000.0,"OtherLiabilitiesCurrent_0_Q2_USD":672000.0,"OtherAssetsCurrent_0_Q2_USD":290000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_2_Q2_USD":202000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":676000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":242000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":449000.0,"OperatingIncomeLoss_2_Q2_USD":-31310000.0,"OperatingIncomeLoss_1_Q2_USD":-15541000.0,"OperatingExpenses_2_Q2_USD":31410000.0,"OperatingExpenses_1_Q2_USD":15641000.0,"NonoperatingIncomeExpense_2_Q2_USD":-147000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":32000.0,"NonoperatingIncomeExpense_1_Q2_USD":-81000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":21478000.0,"RestrictedCashNoncurrent_0_Q2_USD":115000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":23267943.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":23305673.0,"TaxesPayableCurrent_0_Q2_USD":106000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":57000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":135905.0,"StockholdersEquity_0_Q2_USD":235656000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":67.45,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":24.56,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.73,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_2_Q2_USD":5900000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":21.73,"RestrictedCash_0_Q2_USD":115000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":2820472.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":47.1,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":483508.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_Q2_shares":26734.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":8107000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":7.36,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":1080101.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":38047000.0,"ShareBasedCompensation_2_Q2_USD":5343000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":100000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":100000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-96518000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":71592000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":23267943.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q2_USD":-15622000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-31507000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":35600000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":1168000.0,"EarningsPerShareDiluted_2_Q2_USD":-1.35,"EarningsPerShareDiluted_1_Q2_USD":-0.67,"EarningsPerShareBasic_1_Q2_USD":-0.67,"EarningsPerShareBasic_2_Q2_USD":-1.35,"Depreciation_2_Q2_USD":171000.0,"CommonStockValue_0_Q2_USD":2000.0,"CommonStockSharesOutstanding_0_Q2_shares":23328771.0,"CommonStockSharesIssued_0_Q2_shares":23328771.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1_Q2_USD":0.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":237228000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":237113000.0,"AssetsCurrent_0_Q2_USD":241417000.0,"Assets_0_Q2_USD":243461000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":5343000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":2849000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2849000.0,"AdditionalPaidInCapital_0_Q2_USD":332172000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":697000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":5710000.0,"AccountsReceivableNetCurrent_0_Q2_USD":100000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-28763000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_2_Q2_USD":-31507000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2_Q2_USD":0.0,"GeneralAndAdministrativeExpense_1_Q2_USD":5658000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-15622000.0,"NetIncomeLoss_1_Q2_USD":-15622000.0,"NetIncomeLoss_2_Q2_USD":-31507000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-28142000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-720000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":99000.0,"LiabilitiesCurrent_0_Q2_USD":7531000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":243461000.0,"Liabilities_0_Q2_USD":7805000.0,"InterestExpenseDebt_2_Q2_USD":2000.0,"InterestExpenseDebt_1_Q2_USD":1000.0,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":-20000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2354000.0,"IncreaseDecreaseInOperatingLeaseLiability_2_Q2_USD":-208000.0,"IncreaseDecreaseInDeferredCharges_2_Q2_USD":0.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":1098000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":100000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-777000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":50000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"IncomeTaxesReceivable_0_Q2_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-31457000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-15622000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":9932000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":-30000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":23305673.0,"Ticker":"KROS","CIK":"1664710","name":"KEROS THERAPEUTICS, INC.","OfficialName":"Keros Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1518748666.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]